|
|
|
12.01.26 - 15:06
|
VieCure Raises $43 Million to Help Democratize Access to the Highest Caliber Cancer Care in Community Practices (Business Wire)
|
|
|
Round led by legendary business icon Mitch Rales, co-founder of Danaher, one of the world's most successful companies, and Northpond Ventures
Funds will accelerate the expansion of VieCure's AI platform and its growing footprint of community oncology clinics
VieCure is partnering with Mitch Rales' business-building firm, New Bearing, to instill in VieCure world-class operational capabilities through the New Bearing Foundational Business System
DENVER--(BUSINESS WIRE)--VieCure, a leading provider of intelligent software platforms for oncology care, has raised $43 million in funding to accelerate its mission to democratize access to precision medicine in community cancer care practices.
The round was led by Mitch Rales, co-founder of Danaher, and Northpond Ventures, with significant participation from Durable Capital Partners, Socium Ventures – a venture firm backed by Cox Enterprises, and Sator Grove Holdings. Additionally, Mitch Rales and Howard “Skip” Burris III, M.D., a past president of the Am...
|
|
|
|
|
07.01.26 - 20:21
|
Patterson Announces Dental President (Business Wire)
|
|
|
Patrik Eriksson Named Dental PresidentST. PAUL, Minn.--(BUSINESS WIRE)--Patterson Companies Inc. has announced the appointment of Patrik Eriksson as Patterson Dental's North American president. Eriksson brings a wealth of experience in the dental and medical technology sectors, with a proven track record of developing customer-centric solutions and building result-oriented cultures, where accountability and high team performance are prioritized.
He will report to Robert Rajalingam, chief executive officer of Patterson Companies, and he will be a member of the company's executive leadership team.
Eriksson comes to Patterson with more than 25 years of experience, most recently serving as CEO at Vimian Group, where he led the company in building a world-class animal health organization, focused on strategic growth through acquisitions and operational improvements. Prior to Vimian, Eriksson held key leadership positions at Danaher & Envista Holdings, Nobel Biocare, KavoKerr, Ormco, and Carestream Dental, wh...
|
|
|
05.01.26 - 22:18
|
Danaher to Present at J.P. Morgan Healthcare Conference (PR Newswire)
|
|
|
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 13, 2026 at 11:15 a.m. PT. The......
|
|
|
|
|
|
|
|
|
|
|
17.12.25 - 13:33
|
Danaher Schedules Fourth Quarter 2025 Earnings Conference Call (PR Newswire)
|
|
|
WASHINGTON, Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2025 on Wednesday, January 28, 2026 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the......
|
|
|
|
|
|
|
|
|
09.12.25 - 22:18
|
Danaher Announces Quarterly Dividend (PR Newswire)
|
|
|
WASHINGTON, Dec. 9, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.32 per share of its common stock, payable on January 30, 2026 to holders of record on December 26, 2025. ABOUT DANAHER......
|
|
|
|
|
|
|
|
|
08.12.25 - 08:39
|
Appointment of Francis Van Parys as Chief Executive Officer (Business Wire)
|
|
|
OXFORD, England--(BUSINESS WIRE)--#Nanopore--Oxford Nanopore Technologies, the company delivering a new generation of molecular sensing technology based on nanopores, today announces the appointment of Francis Van Parys as Chief Executive Officer (“CEO”). Francis will join the Company and the Board as an Executive Director on 2 March 2026.
Francis brings more than 20 years of experience leading multi-billion-dollar life science businesses, with a strong track record of scaling innovation-driven organisations through commercial and operational excellence. He is currently President and CEO of Radiometer, a global leader in acute care diagnostics and part of Danaher Corporation. Previously, Francis held senior leadership roles at Cytiva and GE Healthcare, driving sustained growth and building high-performing teams across Europe, Asia, and North America.
Francis Van Parys will succeed Gordon Sanghera, who has led Oxford Nanopore since its inception in 2005. Gordon will step down from the Board at close of...
|
|
|
03.12.25 - 10:36
|
NVIDIA +3.668% – So nutzen Sie Megatrends richtig (Der Aktionaer)
|
|
|
Es gibt diese Aktien, die ganze Branchen verschieben – und die Jahre später als „naheliegende Erfolgsgeschichten“ gelten. Als hätte man sehen müssen, dass bestimmte Unternehmen ihre Branche verändern. Dass Amazon den Handel neu definiert. Dass Danaher über Jahre hinweg still und leise zur Innovationsmaschine wird....
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
